PDCD1 and cancer: Here, we performed deep shotgun metagenomic sequencing of baseline fecal samples from patients on the CA209-538 clinical trial of ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) for 106 patients with diverse rare cancers (our discovery cohort).